Menopausal hormone therapy and sleep-disordered breathing: Evidence for a healthy user bias

Annals of Epidemiology

Volumn 25, Issue 10, 2015, Pages 779-784.e1

  Mirer, Anna G ^a   Peppard, Paul E ^a   Palta, Mari ^a   Benca, Ruth M ^a   Rasmuson, Amanda ^a   Young, Terry ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Bias (epidemiology); Estrogen replacement therapy; Menopause; Obstructive; Sleep apnea; Sleep apnea syndromes; Women's health

Indexed keywords

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; CLIMACTERIUM; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; OUTCOME ASSESSMENT; POLYSOMNOGRAPHY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; BODY MASS; DRINKING BEHAVIOR; HORMONE SUBSTITUTION; MIDDLE AGED; ODDS RATIO; RISK FACTOR; SLEEP APNEA SYNDROMES; SMOKING; STATISTICAL BIAS; STATISTICS AND NUMERICAL DATA; WISCONSIN; WOMEN'S HEALTH;

ADULT; ALCOHOL DRINKING; BIAS (EPIDEMIOLOGY); BODY MASS INDEX; COHORT STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; ODDS RATIO; POLYSOMNOGRAPHY; RISK FACTORS; SLEEP APNEA SYNDROMES; SMOKING; WISCONSIN; WOMEN'S HEALTH;

EID: 84941139830     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2015.07.004     Document Type: Article

References (42)

1. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C.L., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
2. Cauley J.A., Robbins J., Chen Z., Cummings S.R., Jackson R.D., LaCroix A.Z., et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003, 290:1729-1738.
3. Chlebowski R.T., Wactawski-Wende J., Ritenbaugh C., Hubbell F.A., Ascensao J., Rodabough R.J., et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. NEngl J Med 2004, 350:991-1004.
4. Young T., Finn L., Peppard P.E., Szklo-Coxe M., Austin D., Nieto F.J., et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008, 31:1071-1078.
5. Young T., Palta M., Dempsey J., Peppard P.E., Nieto F.J., Hla K.M. Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. Wis Med J 2009, 108:246-249.
6. Tregear S., Reston J., Schoelles K., Phillips B. Obstructive sleep apnea and risk of motor vehicle crash: systematic review and meta-analysis. JClin Sleep Med 2009, 5:573-581.
7. Punjabi N.M., Caffo B.S., Goodwin J.L., Gottlieb D.J., Newman A.B., O'Connor G.T., et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009, 6:e1000132.
8. Redline S., Yenokyan G., Gottlieb D.J., Shahar E., O'Connor G.T., Resnick H.E., et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 2010, 182:269-277.
9. O'Connor G.T., Caffo B., Newman A.B., Quan S.F., Rapoport D.M., Redline S., et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 2009, 179:1159-1164.
10. Redline S., Kump K., Tishler P.V., Browner I., Ferrette V. Gender differences in sleep disordered breathing in a community-based sample. Am J Respir Crit Care Med 1994, 149:722-726.
11. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. NEngl J Med 1993, 328:1230-1235.
12. Peppard P.E., Young T., Barnet J.H., Palta M., Hagen E.W., Hla K.M. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013, 177:1006-1014.
13. Cistulli P.A., Barnes D.J., Grunstein R.R., Sullivan C.E. Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 1994, 49:699-702.
14. Franklin K., Lundgren R., Rabben T. Sleep apnoea syndrome treated with oestradiol and cyclic medroxyprogesterone. Lancet 1991, 338:251-252.
15. Hensley M.J., Saunders N.A., Strohl K.P. Medroxyprogesterone treatment of obstructive sleep apnea. Sleep 1980, 3:441-446.
16. Keefe D.L., Watson R., Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause 1999, 6:196-200.
17. Manber R., Kuo T.F., Cataldo N., Colrain I.M. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. Sleep 2003, 26:163-168.
18. Pickett C.K., Regensteiner J.G., Woodard W.D., Hagerman D.D., Weil J.V., Moore L.G. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. JAppl Physiol 1989, 66:1656-1661.
19. Polo-Kantola P., Rauhala E., Helenius H., Erkkola R., Irjala K., Polo O. Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. Obstet Gynecol 2003, 102:68-75.
20. Saletu-Zyhlarz G., Anderer P., Gruber G., Mandl M., Gruber D., Metka M., et al. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. JSleep Res 2003, 12:239-254.
21. Wesström J., Ulfberg J., Nilsson S. Sleep apnea and hormone replacement therapy: a pilot study and a literature review. Acta Obstet Gynecol Scand 2005, 84:54-57.
22. Young T., Finn L., Austin D., Peterson A. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003, 167:1181-1185.
23. Shahar E., Redline S., Young T., Boland L.L., Baldwin C.M., Nieto F.J., et al. Hormone Replacement Therapy and Sleep-disordered Breathing. Am J Respir Crit Care Med 2003, 167:1186-1192.
24. Bixler E.O., Vgontzas A.N., Lin H.M., Ten Have T., Rein J., Vela-Bueno A., et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001, 163:608-613.
25. Hersh A.L., Stefanick M.L., Stafford R.S. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004, 291:47-53.
26. Watkins E.S. The estrogen elixir: a history of hormone replacement therapy in America 2007, Johns Hopkins University Press, Baltimore.
27. Wisconsin Sleep Cohort Study Manual of Operations. [accessed 13.3.14]. http://sleepcohort.wisc.edu/operations/womens_study/diaries/.
28. Harlow S.D., Gass M., Hall J.E., Lobo R., Maki P., Rebar R.W., et al. Executive summary of the stages of reproductive aging workshop+10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012, 15:105-114.
29. Women's Study Protocol Instruction Sheet. Wisconsin Sleep Cohort Study. [accessed 24.8.15]. http://www.sleepcohort.wisc.edu/operations/womens_study/.
30. Leach M.J., Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev 2012, CD007244.
31. Egeland G.M., Kuller L.H., Matthews K.A., Kelsey S.F., Cauley J., Guzick D. Premenopausal determinants of menopausal estrogen use. Prev Med 1991, 20:343-349.
32. Posthuma W.F., Westendorp R.G., Vandenbroucke J.P. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?. BMJ 1994, 308:1268-1269.
33. Matthews K.A., Kuller L.H., Wing R.R., Meilahn E.N., Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers?. Am J Epidemiol 1996, 143:971-978.
34. Sturgeon S.R., Schairer C., Brinton L.A., Pearson T., Hoover R.N. Evidence of a healthy estrogen user survivor effect. Epidemiology 1995, 6:227-231.
35. Humphrey L.L., Chan B.K.S., Sox H.C. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med 2002, 137:273-284.
36. Lawlor D.A., Davey Smith G., Ebrahim S. Socioeconomic position and hormone replacement therapy use: explaining the discrepancy in evidence from observational and randomized controlled trials. Am J Public Health 2004, 94:2149-2154.
37. Ha-Vinh P., Clavaud H., Sauze L. Caractéristiques individuelles et mortalité associées au traitement hormonal substitutif de la ménopause: étude d'une cohorte française de femmes d'âge compris entre 60 et 69 ans. JGynécol Obstét Biol Reprod 2010, 39:453-465.
38. Stefanick M.L. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. Am J Med 2005, 118:64-73.
39. Michels K.B. Hormone replacement therapy in epidemiologic studies and randomized clinical trials - are we checkmate?. Epidemiology 2003, 14:3-5.
40. Hernán M.A., Alonso A., Logan R., Grodstein F., Michels K.B., Willett W.C., et al. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology 2008, 19:766-779.
41. Jordan A.S., McEvoy R.D. Gender differences in sleep apnea: epidemiology, clinical presentation and pathogenic mechanisms. Sleep Med Rev 2003, 7:377-389.
42. Shepertycky M.R., Banno K., Kryger M.H. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep 2005, 28:309-314.